Efficiency in Healthcare is Needed as the Aging and Chronically Ill Population is Set to Increase

 

As healthcare needs and costs continue to soar, efficiency in healthcare will become increasingly vital. The industry faces the daunting challenge of providing high-quality care to an aging and increasingly ailing population. By 2025, chronic diseases will affect 49 percent of Americans, and by 2030, 21 percent of Americans will be over 65. Furthermore, the healthcare system is poised to accommodate an additional 30 million new patients by 2025. As resources remain limited, the crucial question that arises is: how can we provide care in a more efficient and effective manner?

The discussion was explored on an episode of “I Don’t Care,” with host Kevin Stevenson, and his guest Sanjeev Agrawal, President and Chief Operating Officer at LeanTaas. The episode examined how healthcare predictive analytics and mathematical principles can help hospitals and healthcare providers make better decisions to improve efficiency and patient care.

Stevenson and Agrawal’s conversation also included:

  • How the healthcare industry can learn from asset-intensive businesses like Delta Airlines to make the best use of resources
  • The problems with the current metrics used in healthcare, particularly block utilization in operating rooms
  • How patterns in data can help to identify and repurpose time, improving efficiency in operating rooms

Sanjeev Agrawal brings a wealth of experience to the conversation. Prior to his role at LeanTaas, he served as the first head of product marketing for Google. After leaving Google, Agrawal founded three startups before landing his current role in LeanTaas. Agrawal, the author of “Better Healthcare Through Math”, has been recognized as one of the top 100 entrepreneurs in healthcare and featured on CNBC.

Recent Episodes

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…